Imperial began as a business printer and evolved and broadened over four decades to fully support clinical studies in a million different ways. Today, printed materials are still popular. In our U.S. and U.K. facilities, our presses keep rolling, as the sponsors and CROs we…
-
Clinical Trial Business InsightsParticipant Engagement
Clinical Study Startup and Execution: Hidden Causes Behind Big Delays
by Dan McDonaldby Dan McDonaldBefore you plan your next study, please read this first. Planning and conducting a clinical trial presents numerous challenges, and we find that many sponsors and CROs repeatedly miss important areas when planning their studies. These planning gaps result in: Delayed clinical study startup Missing…
-
Clinical Trial Business InsightsClinical Trial Materials Development and PrintingParticipant Engagement
Today’s Clinical Trials: Do Print Materials Still Pack a Punch?
by Hope Cullenby Hope CullenEven in this digital age, printed clinical trial materials remain popular and important tools for keeping sites and patients engaged. Clinical study sites rely on printed materials to gain local interest, and popular examples include: Posters Flyers Brochures Fact sheets These printed tools are designed…
-
Ancillary Clinical Trial Supplies and EquipmentClinical Trial Business InsightsClinical Trial Materials Development and PrintingParticipant EngagementTranslation of Clinical Trial Materials
Clinical Trial Efficiencies: The Power of a Single Workstream
by Dan McDonaldby Dan McDonaldThe management time needed to corral many different elements during a trial is immense. In the buildup to a research study, clinical operations teams often focus on items such as study startup, site initiation and activation, supply chain, monitoring, data management, and safety. And there…
-
Clinical Trial Business InsightsParticipant Engagement
Decentralized Clinical Studies: What Does the Future Look Like?
Clinical trials have existed for centuries, shaped by brilliant minds, historical events, and medical crises. When COVID emerged, many research sites closed or patients stayed away as non-COVID trials paused. Decentralized clinical studies experienced a metamorphosis, putting into action what had previously been primarily ideas.…